Fig. 6From: Analysis of gene expression levels and their impact on survival in 31 cancer-types patients identifies novel prognostic markers and suggests unexplored immunotherapy treatment options in a wide range of malignanciesImmunotherapy based treatments approved by FDA (A) and new options and molecular targets selected in the present study (B)Back to article page